Chemical compounds

Details Chemical compounds Chemical compounds

2007-12-04

2007-12-04

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S216000

Reexamination Certificate

active

10344758

ABSTRACT:
The invention provides compounds of formula (I): as modulators of chemokine and H1 receptor activity. The compounds are especially useful in the treatment of asthma and rhinitis.

REFERENCES:
patent: 4335127 (1982-06-01), Vandenberk et al.
patent: 4853393 (1989-08-01), Zimmermann
patent: 5143923 (1992-09-01), Hrib et al.
patent: 5210086 (1993-05-01), George et al.
patent: 6140344 (2000-10-01), Gong et al.
patent: 6518286 (2003-02-01), Baxter et al.
patent: 2003/0050309 (2003-03-01), Aquila et al.
patent: 2003/0134840 (2003-07-01), Baxter et al.
patent: 0124476 (1984-11-01), None
patent: 0184258 (1986-05-01), None
patent: 0288563 (1988-11-01), None
patent: 0 429 341 (1991-05-01), None
patent: 0 429 341 (1991-05-01), None
patent: 0 515 240 (1992-11-01), None
patent: 0661266 (1995-07-01), None
patent: 0903349 (1999-03-01), None
patent: 2 675 801 (1992-10-01), None
patent: 2724382 (1996-03-01), None
patent: 1 243 991 (1971-08-01), None
patent: 03264579 (1991-11-01), None
patent: 0904646 (1997-02-01), None
patent: 09077742 (1997-03-01), None
patent: WO 96/14317 (1996-05-01), None
patent: WO 96/29330 (1996-09-01), None
patent: WO 97/10207 (1997-03-01), None
patent: WO97/42956 (1997-11-01), None
patent: WO 97/49680 (1997-12-01), None
patent: WO99/04794 (1999-02-01), None
patent: WO 99/37617 (1999-07-01), None
patent: WO 99/37619 (1999-07-01), None
patent: WO99/38514 (1999-08-01), None
patent: WO00/29377 (2000-05-01), None
patent: WO00/35877 (2000-06-01), None
patent: WO 00/58305 (2000-10-01), None
patent: WO01/14333 (2001-03-01), None
patent: WO 01/92227 (2001-12-01), None
patent: WO 02/30899 (2002-04-01), None
patent: WO03/18566 (2003-03-01), None
patent: WO 03/018556 (2003-03-01), None
Emonds-alt et al. “Preparation of . . . ” Ca 119:8684 (1993).
Acs et al. “Preparation of n-4-piperidinylbutylcarboxamides . . . ” CA 138:287532 (2003).
Baxter “Preparation of piperidinyl compounds . . . ” CA 133:266738 (2000).
Chemical Abstracts, vol. 97, 1982, Printout for Vandenberk et al.
Herndon et al., “Ketanserin Analogues: Structure-Affinity Relationships for 5-HT.sub.2 and 5-HT.sub.1C Serotonin Receptor Binding”, J. Med. Chem., vol. 35:4903-4910 (1992).
Hrib et al., “Benzisoxazole-and Benzisothiazole-3-carboxamides as Potential Atypical Antipsychotic Agents”, J. Med. Chem., vol. 37:2308-2314 (1994).
C.G.M. Janssen et al., “Synthesis of .sup.3 H and .sup.14 C Ketanserin”, Journal of Labelled Components and Radiopharmaceuticals, vol. XXV, No. 7, pp. 783-792 (1988).
Chem. Abstracts, Accession No. 1980:586265, Carissimi et al. Farmaco, Edizion Scientifica (1980), 35(6), 504-26.
King “Medicinal chemistry: principle and practice” pp. 206-209 (1994).
Rubini et al. “Synthesis of isosteric methylen-oxy....” Tetrahedron v. 42, pp. 6039-45 (1986).
Bundgaard, “Design of prodrugs”, p. 1, 1986.
CAS printout for Kikuchi et al., Chem. Abs. 128:22926 (JP 09291090).
CAS printout for Takahashi et al., Chem. Abs. 128:294706 (JP 10077271).
Cohen et al., “Cytokine function: A study in biologic diversity”, CA 125:3527, 1996.
Ian T. Forbes et al., “(R)-3, N-Dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl)propyl]benzenesulfonamide:The First Selective 5-HT7Receptor Antagonist” 41 Journal of Medicinal Chemistry 5, 655-657 (1998).
Jean-Luc Malleron et al., “New Indole Derivatives as Potent and Selective Serotonin Uptake Inhibitors” 36 J. Med. Chem. 1194-1202 (1993).
STN International, File Caplus, Caplus accession no. 1996:113480, Document no. 124:220549, Kharkovskij Farmatsevticheskij Institut: Piperdylamide of 3,5-dibromo-4-aminobenzene-sulfonylaminosuccinic acid which produces neuroptic and diruetic effects; & SU, A1, 1824396, 1993630.

Affiliated with

Also associated with

Rating

Chemical compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemical compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3890205